KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Equity Ratio (2017 - 2026)

ClearPoint Neuro's Equity Ratio history spans 14 years, with the latest figure at 0.29 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 55.75% to 0.29 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.29, a 55.75% decrease, with the full-year FY2025 number at 0.29, down 55.75% from a year prior.
  • Equity Ratio hit 0.29 in Q4 2025 for ClearPoint Neuro, up from 0.26 in the prior quarter.
  • Over the last five years, Equity Ratio for CLPT hit a ceiling of 0.74 in Q4 2021 and a floor of 0.26 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.59 across 5 years, with a median of 0.65 in 2024.
  • Biggest five-year swings in Equity Ratio: soared 9316.08% in 2021 and later tumbled 63.55% in 2025.
  • Tracing CLPT's Equity Ratio over 5 years: stood at 0.74 in 2021, then fell by 10.64% to 0.66 in 2022, then decreased by 25.34% to 0.5 in 2023, then surged by 30.54% to 0.65 in 2024, then plummeted by 55.75% to 0.29 in 2025.
  • Business Quant data shows Equity Ratio for CLPT at 0.29 in Q4 2025, 0.26 in Q3 2025, and 0.31 in Q2 2025.